1) Optical imaging for surgical guidance. The Stoyanova Lab develops various targeted imaging agents such as antibody-conjugated to fluorescence dyes for tumor imaging and surgical guidance for precise excisions of metastatic lesions.

2) Imaging modalities for cancer. The Stoyanova lab develops new positron emission tomography (PET) imaging modalities for epithelial cancers to improve cancer detection and monitor treatment responses to cancer therapies.